Secretion of cefoxitin in breast milk following short-term prophylactic administration in caesarean section.
In this study we investigated whether cefoxitin administered prophylactically to the mother in caesarean section could be demonstrated in breast milk. For this purpose 25 samples of breast milk were obtained from 18 patients to whom either 2 or a total of 4 g of cefoxitin had been administered during and following caesarean section. Cefoxitin was determined by means of a modified HPLC method and appeared demonstrable in only one case in a concentration of 0.9 micrograms/ml. On these grounds nursing need not be advised against when prophylactic cefoxitin is briefly administered to the mother during and following caesarean section.
D001942:Breast Feeding; D002440:Cefoxitin / Q000009:adverse effects / Q000493:pharmacokinetics*; D002585:Cesarean Section; D002851:Chromatography, High Pressure Liquid; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008895:Milk, Human / Q000378:metabolism*; D011247:Pregnancy
D002440:Cefoxitin